Randal Voss
Papers
1
Total Citations
64
H-Index
1
About
Randal Voss is a prominent neuroscientist whose research focuses on the molecular mechanisms underlying neurodegenerative diseases, particularly Alzheimer's disease. His most cited work, "Clioquinol and other hydroxyquinoline derivatives inhibit Aβ(1–42) oligomer assembly" (2009, 64 citations), represents a significant contribution to understanding how metal-binding compounds can disrupt the aggregation of amyloid-beta peptides, a key pathological hallmark of Alzheimer's. This study demonstrated that hydroxyquinoline derivatives, including clioquinol, effectively prevent the formation of toxic Aβ oligomers, offering a potential therapeutic strategy for targeting early-stage protein misfolding. Voss's research has been instrumental in advancing the field of metal chelation therapy for Alzheimer's, providing mechanistic insights into how these compounds modulate peptide assembly and reduce neurotoxicity. His work bridges chemistry and neuroscience, highlighting the importance of small-molecule interventions in combating protein aggregation diseases. With a citation impact that underscores the relevance of his findings, Voss continues to explore the intersection of metal homeostasis and amyloid pathology, contributing to the development of novel therapeutic approaches for neurodegenerative disorders.
Research Focus
Key Achievements
Top Papers
- 1